Select your country or region to view content specific to your country.
Seeplex® HPV6 ACE Genotyping Seegene's Seeplex® CMV ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Mar 03, 2009| Seeplex® HPV6 ACE Detection
Simultaneous detection of 12 major respiratory viruses Obtained Medical Device License By Health Canada : Seeplex® RV12 ACE Detection
Nov 04, 2008| Seeplex® RV12 ACE Detection
Seeplex® RV5 ACE Screening Rapid screening of most prevalent respiratory viruses Seeplex® RV5 ACE Screening has been given a Medical Device License by Health Canada. The licenses will enhance the opportunity in the Canadian market.NOT AVAILABLE IN US Seeplex® RV 12 ACE Detection Simultaneously detection 12 major respiratory viruses Seeplex® RV 12 ACE Detection has been given a Medical Device License by Health Canada. The licenses will enhance the opportunity in the Canadian market.
Nov 03, 2008| Seeplex® RV12 ACE Detection , Seeplex® RV5 ACE Screening
Seeplex® HPV18 ASE Genotyping Seegene's Seeplex® HPV18 ASE Genotyping has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Jul 31, 2008| Seeplex® HPV18 ASE Genotyping
Seegene's Seeplex® STD6 ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Jul 21, 2008| Seeplex® STD6 ACE Detection
Seeplex® CT ACE Detection Seeplex® CMV ACE Detection Chlamydia product received COC (Certificate of conformity) by EU NB (Notified Body). ITC (Institute for Testing and Certification).
Jul 15, 2008| Seeplex® CT ACE Detection , Seeplex® CMV ACE Detection
Seeplex® STD6 ACE Detection Simultaneously detecting 6 different STD pathogens Seeplex® STD ACE Detection series are designed to simultaneously detect 6 sexually transmitted disease (STD) pathogens Seeplex® STD6 ACE Detection is designed to simultaneously detect 6 sexually transmitted disease(STD) pathogens from patients' samples (urine, urethral swab, vaginal swab, genital lesion swab, cervical brush/swab or liquid-based cytology specimen (ex. ThinPrep®, specimen transport medium, etc.)). The conventional methods (ELISA, Giemsa stain, culture, etc.) to detect STD pathogens take several days or suffer from poor sensitivity. Therefore, many of the recently developed diagnostic methods employ PCR methods. Among them, Seegene's STD Detection is outstanding in terms of sensitivity and specificity using a novel DPO™ technology and currently detects multiple pathogens causing sexually transmitted infections by Mutiplex PCR
Jul 01, 2008| Seeplex® STD6 ACE Detection
Seeplex® Sepsis Screening SetScreening for sepsis-causing pathogensSeeplex® Sepsis Group Screening Set can screen for sepsis-causing pathogenes from periodontal and caries joint fluid, cerebrospinal fluid, blood cultures, urine, sputum, and other body fluids. * Launched Seeplex® Sepsis DNA Test * Introduced at the 2008 Annual Meeting and Clinical Lab Expo of the American Association for Clinical Chemistry (AACC) The conventional method for sepsis diagnostics is blood culture. However, it takes up to several days for the result. Therefore it is not appropriate for a patient in an intensive care unit. Seeplex® Sepsis Group Screeing Set enables simultaneous screening for gram-negative and -positive bacteria and fungi that cause sepsis with multiplex PCR and provides more rapid results than culture testing.
Jul 01, 2008| Seeplex® Sepsis DNA Test